about
Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-cultureAn open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis.Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomasFree fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4Toward a drug development path that targets metastatic progression in osteosarcoma.Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopyMetastasis suppressor pathways--an evolving paradigm.Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapyAllelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis.The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression.Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.Kinetics of metastatic breast cancer cell trafficking in bone.Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-4353,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesisSubsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression.Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancyDo we need to redefine a cancer metastasis and staging definitions?MTBP inhibits migration and metastasis of hepatocellular carcinoma.Clinical and biological significance of KISS1 expression in prostate cancer.Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells.A MSC-ing link in metastasis?Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.Unraveling the 'TGF-β paradox' one metastamir at a time.Metastasis suppressors genes in cancer.Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload.Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.Metastamir: the field of metastasis-regulatory microRNA is spreading.Linking metastasis suppression with metastamiR regulation.Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
P50
Q24796529-EBEF31E7-5492-4A50-8A42-DF00EE9E1639Q30410564-3E556C49-C13E-4C77-A006-31969C8929AAQ30437720-6F0BC49D-434B-4620-BA37-49353ADC6518Q33420925-142B1716-D25C-480B-A35D-0C630B416F23Q33483295-3C82EE0A-2DE3-4D13-89D1-F2F3C0A4A49FQ33643007-2A389F17-C7AD-4237-BEE3-A7457B897E97Q33787201-5EE1A2EF-9D4F-4EBB-9132-36A48E2A5122Q34000430-5BE64F45-720C-42EB-8008-34C27E19D06CQ34052760-2E595474-8353-4A2C-9B16-1EA5C82B7375Q34205467-EF28EC75-FC6B-4BAC-B871-29A1AF42CF56Q34219023-43D66B5F-78B9-43EF-9903-782E08B3CC0DQ34237948-5FCB998D-E6C4-4F86-BA6A-26C23B6AD938Q34302171-C49C99E8-3782-475D-BEE8-FD7B1E3CB7C2Q34580173-6DED27B8-9062-4937-A331-0021F74C5769Q34766640-A75B2E62-AA62-4275-B8B5-B666B8479B9EQ34871669-55CD0CCA-3E81-412C-884C-0664E14B5CB1Q35046540-AA2A0C83-557C-4577-A2DC-4A889B3552E4Q35541678-B5A06098-4BEB-4B7F-9CF0-CA828005DF7AQ35645355-AF11CB07-E142-483E-952D-DD65474CA6C6Q35676476-3367968A-0513-4795-975C-97982E1F74B3Q35792651-36DFFC28-B261-4E35-A1A1-1DB747D42949Q35878427-FC5AA759-EB34-4717-A3B2-60525437A3ECQ35952025-E4CEFEED-9726-46A9-9B95-65A3AE3E30EDQ36174845-8E731231-D002-4BC6-84D1-13DFE3974D84Q36307011-71E2E2B4-29F2-4867-A762-F20923109107Q36413867-50532186-899A-4DEB-8DDF-EE6A41817FE1Q36494579-DE94C93B-25B3-477E-B248-5133864BF3E8Q36865586-1CBF8421-0AB3-47C4-99C6-9AE11FDDA43BQ36903052-41568579-BBB8-4964-A1DB-4AC9A3CA7BB3Q37086775-B540E502-0711-4C25-8E99-BF3ADE989AD1Q37141501-58BA5942-48B8-4D0F-89AE-FAE3DE273853Q37233956-EB5E0B24-5F1A-4DC9-A601-352ED3226B5DQ37252529-18A75234-026C-4D8A-AD8D-F81AD2B58946Q37368106-45FC4B0D-EC68-43A9-8632-CF67A8654A9AQ37368116-A31FE61A-CC48-487D-A74E-5A0D748131E2Q37368130-982AAA20-5429-448B-937E-0A47FE0B36F2Q37373142-65467BAE-E1FE-4410-834B-E23099152BB6Q37373263-AA6337AA-4D87-46A2-B38D-73509B0E71CFQ37377799-9724EAC7-3531-4148-A9A3-37E8BD27CA40Q37391196-754C8A72-C5CC-4497-A2AF-769B0EB15EFA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Danny R Welch
@ast
Danny R Welch
@en
Danny R Welch
@es
Danny R Welch
@nl
Danny R Welch
@sl
type
label
Danny R Welch
@ast
Danny R Welch
@en
Danny R Welch
@es
Danny R Welch
@nl
Danny R Welch
@sl
altLabel
Dan R. Welch
@en
prefLabel
Danny R Welch
@ast
Danny R Welch
@en
Danny R Welch
@es
Danny R Welch
@nl
Danny R Welch
@sl
P108
P1006
P214
P244
P1006
P1053
B-7310-2009
P106
P108
P21
P213
0000 0000 3949 9946
P214
P244
P31
P3829
P496
0000-0002-1951-4947
P69
P734
P735
P7859
lccn-n85334705